OWC Pharmaceutical Research Corp (OWCP)

[Ninja007]

That's the secret. There are no partners. No TEVA, no Medmar distribution deal and no patents.

Their 8k February 22,2017

(i) On February 22, 2017, a total of 550,000 units at a price of $0.70 per unit, each consisting of one Share and on one Class L Warrant exercisable at $1.40 for a period of 18 months for total proceeds of $385,000;
(ii) On February 13, 2017, a total of 1,734,000 units at a price of $0.50 per unit, each consisting of one Share and one Class K Warrant exercisable to $1.00 for a period of 18 months for total proceeds of $867,000;
(iii) On January 17, 2017, a total of 520,000 units at price of $0.25 per unit, each consisting of one Share and one Class I Warrant exercisable at $0.50 for a period of 24 months for total proceeds of $130,000;
(iv) On January 13. 2017, a total of 588,235 units at $0.17 per unit, each consisting of one Share and one Class H Warrant exercisable at $0.40 for a period of 36 months, for total proceeds of $100,000; and
(v) On January 9, 2017, a total of 1,097,230 units at $0.13 per unit, each consisting of one Share and one Class G Warrant exercisable at $0.25 for a period of 24 months and one Class H Warrant exercisable at $0.40 for a period of 36 months for total proceeds of $142,640.

In addition, on February 3, 2017, the Registrant issued a total 300,000 restricted Shares to Lyons Capital, LLC, a Florida limited liability company, for business consulting services as well as the Registrant's participation in 2017 WSC Conference Event being held at the Hilton Double Tree, Boca Raton, FL on March 1, 2017.

The issuance of the Shares and Warrants was made in reliance upon the exemptions provided in Section 4(2) of the Securities Act of 1933, as amended (the "Act") and Regulation S and Regulation D promulgated by the SEC under the Act.

Easy.